Related Experiment Video
Updated: Apr 20, 2026
03:34
Assessing Social Dominance in Mouse Models Using the Tube Test
Published on: June 6, 2025
1.9K
MicroRNA-124 modulates social behavior in frontotemporal dementia
Andrew E Arrant1, Erik D Roberson1
1Center for Neurodegeneration and Experimental Therapeutics, Departments of Neurology and Neurobiology, Birmingham, Alabama, USA.
Nature Medicine
|December 5, 2014
Summary
Frontotemporal dementia (FTD) causes social dysfunction due to reduced microRNA-124. This leads to altered glutamate receptors in the brain, impacting social behavior in FTD patients.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Frontotemporal dementia (FTD) is a progressive neurodegenerative disorder.
- FTD is characterized by profound social and behavioral changes.
- The underlying molecular mechanisms of FTD-related social dysfunction remain incompletely understood.
Purpose of the Study:
- To investigate the role of microRNA-124 (miR-124) in the pathophysiology of social dysfunction in FTD.
- To examine the impact of altered miR-124 expression on glutamate receptor composition in the prefrontal cortex of FTD patients.
Main Methods:
- Analysis of miR-124 expression levels in post-mortem brain tissue from FTD patients and controls.
- Assessment of glutamate receptor subunit expression and localization in the prefrontal cortex.
- Correlation analysis between miR-124 levels, glutamate receptor changes, and social cognition deficits.
Main Results:
- Significantly decreased expression of miR-124 was observed in the prefrontal cortex of individuals with FTD.
- Reduced miR-124 levels were associated with altered expression and distribution of key glutamate receptor subunits (e.g., GRIA1, GRIN2B).
- These molecular changes correlated with the severity of social dysfunction observed in FTD.
Conclusions:
- Decreased microRNA-124 expression is a key molecular event contributing to social dysfunction in frontotemporal dementia.
- Altered glutamate receptor composition, driven by reduced miR-124, underlies the prefrontal cortex changes seen in FTD.
- Targeting miR-124 or glutamate pathways may offer potential therapeutic strategies for FTD.
